These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
805 related articles for article (PubMed ID: 22421322)
1. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322 [TBL] [Abstract][Full Text] [Related]
2. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide. Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316 [TBL] [Abstract][Full Text] [Related]
3. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
4. Thiomer nanoparticles: stabilization via covalent cross-linking. Barthelmes J; Dünnhaupt S; Hombach J; Bernkop-Schnürch A Drug Deliv; 2011 Nov; 18(8):613-9. PubMed ID: 22111974 [TBL] [Abstract][Full Text] [Related]
5. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery. Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318 [TBL] [Abstract][Full Text] [Related]
6. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Wang X; Chi N; Tang X Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400 [TBL] [Abstract][Full Text] [Related]
7. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder. Barthelmes J; Perera G; Hombach J; Dünnhaupt S; Bernkop-Schnürch A Int J Pharm; 2011 Sep; 416(1):339-45. PubMed ID: 21726619 [TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106 [TBL] [Abstract][Full Text] [Related]
9. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Giovino C; Ayensu I; Tetteh J; Boateng JS Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987 [TBL] [Abstract][Full Text] [Related]
10. Development and in vivo evaluation of a new oral nanoparticulate dosage form for leuprolide based on polyacrylic acid. Iqbal J; Vigl C; Moser G; Gasteiger M; Perera G; Bernkop-Schnürch A Drug Deliv; 2011 Aug; 18(6):432-40. PubMed ID: 21557716 [TBL] [Abstract][Full Text] [Related]
11. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Yin L; Ding J; He C; Cui L; Tang C; Yin C Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735 [TBL] [Abstract][Full Text] [Related]
12. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis. Saini D; Fazil M; Ali MM; Baboota S; Ali J Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026 [TBL] [Abstract][Full Text] [Related]
13. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery? Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441 [TBL] [Abstract][Full Text] [Related]
14. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye. Nagarwal RC; Kumar R; Pandit JK Eur J Pharm Sci; 2012 Nov; 47(4):678-85. PubMed ID: 22922098 [TBL] [Abstract][Full Text] [Related]
15. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Qiang F; Shin HJ; Lee BJ; Han HK Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082 [TBL] [Abstract][Full Text] [Related]
16. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443 [TBL] [Abstract][Full Text] [Related]
17. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation. Paliwal R; Paliwal SR; Agrawal GP; Vyas SP Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712 [TBL] [Abstract][Full Text] [Related]
18. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa. Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123 [TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Makhlof A; Tozuka Y; Takeuchi H Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939 [TBL] [Abstract][Full Text] [Related]
20. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Mahmoud AA; El-Feky GS; Kamel R; Awad GE Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]